Correlation Between Rekah Pharmaceutical and Aviv Arlon
Can any of the company-specific risk be diversified away by investing in both Rekah Pharmaceutical and Aviv Arlon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rekah Pharmaceutical and Aviv Arlon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rekah Pharmaceutical Industry and Aviv Arlon, you can compare the effects of market volatilities on Rekah Pharmaceutical and Aviv Arlon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rekah Pharmaceutical with a short position of Aviv Arlon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rekah Pharmaceutical and Aviv Arlon.
Diversification Opportunities for Rekah Pharmaceutical and Aviv Arlon
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Rekah and Aviv is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Rekah Pharmaceutical Industry and Aviv Arlon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aviv Arlon and Rekah Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rekah Pharmaceutical Industry are associated (or correlated) with Aviv Arlon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aviv Arlon has no effect on the direction of Rekah Pharmaceutical i.e., Rekah Pharmaceutical and Aviv Arlon go up and down completely randomly.
Pair Corralation between Rekah Pharmaceutical and Aviv Arlon
Assuming the 90 days trading horizon Rekah Pharmaceutical is expected to generate 2.58 times less return on investment than Aviv Arlon. But when comparing it to its historical volatility, Rekah Pharmaceutical Industry is 2.69 times less risky than Aviv Arlon. It trades about 0.1 of its potential returns per unit of risk. Aviv Arlon is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 109,000 in Aviv Arlon on November 29, 2024 and sell it today you would earn a total of 7,900 from holding Aviv Arlon or generate 7.25% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Rekah Pharmaceutical Industry vs. Aviv Arlon
Performance |
| Timeline |
| Rekah Pharmaceutical |
| Aviv Arlon |
Rekah Pharmaceutical and Aviv Arlon Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rekah Pharmaceutical and Aviv Arlon
The main advantage of trading using opposite Rekah Pharmaceutical and Aviv Arlon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rekah Pharmaceutical position performs unexpectedly, Aviv Arlon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aviv Arlon will offset losses from the drop in Aviv Arlon's long position.| Rekah Pharmaceutical vs. Kamada | Rekah Pharmaceutical vs. Bet Shemesh Engines | Rekah Pharmaceutical vs. Unitronics | Rekah Pharmaceutical vs. PCB Tec |
| Aviv Arlon vs. First International Bank | Aviv Arlon vs. Harel Insurance Investments | Aviv Arlon vs. Magic Software Enterprises | Aviv Arlon vs. Petrochemical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |